Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

110.36
-2.1100-1.88%
Post-market: 110.360.00000.00%16:59 EDT
Volume:10.63M
Turnover:1.17B
Market Cap:191.90B
PE:35.71
High:111.64
Open:111.54
Low:109.54
Close:112.47
52wk High:137.49
52wk Low:81.97
Shares:1.74B
Float Shares:1.70B
Volume Ratio:1.47
T/O Rate:0.62%
Dividend:2.48
Dividend Rate:2.25%
EPS(TTM):3.09
EPS(LYR):3.73
ROE:10.58%
ROA:5.33%
PB:3.75
PE(LYR):29.59

Loading ...

Abbott Laboratories Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Abbott Labs is Maintained at Buy by UBS

Dow Jones
·
Jul 29

Movement Alert|Abbott Laboratories Rises 3.07% in Regular Trading, FDA Approves Its Exclusive Colorectal Cancer Blood Screening Test

Market Focus
·
Jul 28

Abbott price target lowered to $125 from $135 at UBS

TIPRANKS
·
Jul 28

Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating

MT Newswires Live
·
Jul 28

Abitare In Publishes 2025 Sustainability Report, Underscoring Urban Regeneration Strategy

TIPRANKS
·
Jul 28

Leah Bennett: Where to Invest After the AI-Chip Stock Surge

Dow Jones
·
Jul 27

Freenome, Abbott Laboratories' Colorectal Cancer Screening Test Approved by FDA; Freenome Earns $100 Million Milestone Payment

MT Newswires Live
·
Jul 27

US Companies Face Rise in Cyber Attacks

Reuters
·
Jul 27

FDA Approves Freenome’S Simplescreen™ Crc Blood-Based Screening Test Abbott to Commercialize in the U.S.

Reuters
·
Jul 27

Freenome, Abbott announce FDA approval of SimpleScreen CRC

TIPRANKS
·
Jul 27

Freenome- Freenome to Receive $100 Mln Milestone Payment from Abbott for FDA Approval

THOMSON REUTERS
·
Jul 27

Dexcom Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 25

Abbott Laboratories Wins Dismissal of Shareholder Lawsuit Stemming from 2022 Infant Formula Recall, Court Ruling Shows

THOMSON REUTERS
·
Jul 25

Abbott Wins Dismissal of Shareholder Lawsuit over 2022 Infant Formula Recall

Reuters
·
Jul 25

Abitare In Publishes Shareholders’ Meeting Voting Summary

TIPRANKS
·
Jul 25

Movement Alert|Abbott Laboratories Rises 3.03% in Regular Trading, Multiple Institutions Raise Target Prices Following Strong Q2 Earnings

Market Focus
·
Jul 24

Medical-device Stocks are in the Bargain Bin. 6 to Buy.

Dow Jones
·
Jul 24

Abbott Stock And 2 Dividend Ideas For Retirement Income

Simply Wall St.
·
Jul 24

Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating

MT Newswires Live
·
Jul 22